IRIS
CIRANNI, Annamaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 813
EU - Europa 637
AS - Asia 157
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.610
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 809
IE - Irlanda 195
SE - Svezia 191
CN - Cina 135
IT - Italia 62
DE - Germania 44
UA - Ucraina 42
GB - Regno Unito 29
BE - Belgio 28
FI - Finlandia 25
IN - India 14
FR - Francia 10
CA - Canada 4
NL - Olanda 4
RU - Federazione Russa 4
CL - Cile 2
KR - Corea 2
SG - Singapore 2
VN - Vietnam 2
BG - Bulgaria 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
LV - Lettonia 1
PL - Polonia 1
Totale 1.610
Salva come PNG Salva come JPEG
Città #
Dublin 195
Chandler 189
Nyköping 95
Jacksonville 88
Ashburn 69
Ann Arbor 64
Beijing 45
Dearborn 35
Messina 31
Princeton 31
Medford 28
Brussels 24
Cambridge 23
Bremen 20
Des Moines 20
New York 15
Boardman 10
Nanjing 10
Jinan 9
Shenyang 9
Tianjin 9
Wilmington 9
Hyderabad 8
Lancaster 8
Woodbridge 8
Palo Del Colle 7
Ningbo 6
Zhengzhou 6
Falls Church 5
Hangzhou 5
Hebei 5
Pune 5
Taizhou 5
Haikou 4
Los Angeles 4
Waanrode 4
Anaheim 3
Fuzhou 3
Houston 3
Ottawa 3
Rome 3
San Jose 3
San Mateo 3
Seattle 3
Taiyuan 3
Washington 3
Augusta 2
Bari 2
Catanzaro 2
Dong Ket 2
Hefei 2
Kunming 2
Namdong-gu 2
Northampton 2
San Antonio 2
San Filippo 2
Alba 1
Auburn Hills 1
Birmingham 1
Bonavista 1
Changsha 1
Chengdu 1
Cisano Bergamasco 1
Cranford 1
Dalian 1
Guangzhou 1
Helsinki 1
Hongtong 1
Hull 1
Klyuchik 1
Kraków 1
Milan 1
Nanchang 1
Norwalk 1
Novokuznetsk 1
Porto Torres 1
Reston 1
Rochester 1
Sofia 1
Tappahannock 1
Totale 1.182
Salva come PNG Salva come JPEG
Nome #
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 81
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 81
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 69
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 68
null 67
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 65
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 64
Pilot study of flavocoxid in ambulant DMD patients. 62
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 62
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 61
Miopatie metaboliche 60
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 60
null 58
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 58
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 56
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 53
Calpain 3 deficiency in Quail Eater's disease 52
Telomere length modulation in astroglial brain tumors 52
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 52
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 47
Intracranial aneurysm management in patients with late-onset Pompe disease (LOPD) 43
null 42
Role of calcineurin/NFAT on muscle regeneration in dystrophic process. 36
Expression of the trascription factor NFkB in different muscular dystrophies 35
Implication of SIRT1 and its downstream pathways in dystrophic process. 31
Pilot study of flavocoxid in ambulant DMD patients. 28
Nusinersen modulates proteomics profiles of cerebrospinal fluid in spinal muscular atrophy type 1 patients 28
null 27
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 27
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 25
Pilot study of flavocoxid in ambulant DMD patients. 23
Tubular aggregates: do they help in diagnosing neuromuscular disorders ? 23
null 22
null 18
Pilot study of flavocoxid in ambulant DMD patients. 17
Totale 1.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020209 27 9 1 14 1 38 27 20 3 38 29 2
2020/2021211 18 0 44 14 43 11 7 11 5 38 11 9
2021/2022269 5 37 1 9 16 2 34 9 2 60 22 72
2022/2023632 45 73 31 52 58 53 8 52 238 2 18 2
2023/2024166 11 26 5 31 20 45 6 7 0 15 0 0
Totale 1.653